SFI
LEGN icon

Susquehanna Fundamental Investments’s Legend Biotech LEGN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,746
Closed -$1.95M – 973
2024
Q1 		$1.95M Buy
+34,746
New +$2.1M 0.09% 237
2022
Q1 		– Sell
-9,242
Closed -$431K – 1612
2021
Q4 		$431K Sell
9,242
-420
-4% -$21.3K 0.01% 970
2021
Q3 		$489K Buy
9,662
+4,322
+81% +$180K 0.01% 1228
2021
Q2 		$219K Buy
+5,340
New +$181K ﹤0.01% 1460

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Susquehanna Fundamental Investments's LEGN Position: Q2 2024 in Review

Susquehanna Fundamental Investments sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 34,746 shares — an estimated $1.95M sold.

Susquehanna Fundamental Investments first reported a position in LEGN in Q2 2021 and held it in 4 quarters. The position peaked at $1.95M in Q1 2024. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • Susquehanna Fundamental Investments reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 34,746 Legend Biotech shares in Q2 2024, an estimated $1.95M.
  • Susquehanna Fundamental Investments first reported a position in Legend Biotech in Q2 2021 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Legend Biotech position peaked at $1.95M in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.